Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls.

Zacho J, Yazdanyar S, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG.

Int J Cancer. 2011 Feb 1;128(3):644-52. doi: 10.1002/ijc.25375.

2.

Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin.

Melichar B, Kalábová H, Krcmová L, Kasparová M, Malírová E, Melicharová K, Pecka M, Hyspler R, Solichová D.

Anticancer Res. 2009 Nov;29(11):4813-20.

3.

The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smoking.

Semmler A, Moskau S, Stoffel-Wagner B, Weller M, Linnebank M.

Clin Invest Med. 2009 Dec 1;32(6):E310.

PMID:
20003837
4.

Determinants of homocysteine levels in colorectal and breast cancer patients.

Ferroni P, Palmirotta R, Martini F, Riondino S, Savonarola A, Spila A, Ciatti F, Sini V, Mariotti S, Del Monte G, Roselli M, Guadagni F.

Anticancer Res. 2009 Oct;29(10):4131-8.

5.

Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review.

Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J.

Am J Epidemiol. 2009 Nov 15;170(10):1207-21. doi: 10.1093/aje/kwp275. Epub 2009 Oct 21. Review.

6.

Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk.

Steck SE, Keku T, Butler LM, Galanko J, Massa B, Millikan RC, Sandler RS.

J Nutrigenet Nutrigenomics. 2008;1(4):196-204. doi: 10.1159/000136651. Epub 2008 Jun 2.

7.

SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis.

Anderson DD, Stover PJ.

PLoS One. 2009 Jun 9;4(6):e5839. doi: 10.1371/journal.pone.0005839.

8.

The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer.

Iacopetta B, Heyworth J, Girschik J, Grieu F, Clayforth C, Fritschi L.

Int J Cancer. 2009 Jul 1;125(1):84-90. doi: 10.1002/ijc.24324.

9.

Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study.

Jacobs ET, Ahnen DJ, Ashbeck EL, Baron JA, Greenberg ER, Lance P, Lieberman DA, McKeown-Eyssen G, Schatzkin A, Thompson PA, Martínez ME.

Am J Epidemiol. 2009 Mar 15;169(6):657-66. doi: 10.1093/aje/kwn401. Epub 2009 Jan 15.

10.

Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients.

Guerreiro CS, Carmona B, Gonçalves S, Carolino E, Fidalgo P, Brito M, Leitão CN, Cravo M.

Am J Clin Nutr. 2008 Nov;88(5):1413-8.

PMID:
18996879
11.

Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer.

Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, Liu YT, Li SP, Su P, Cao J, Hamajima N, Tajima K.

Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):203-8.

12.

Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study.

Howard RA, Freedman DM, Park Y, Hollenbeck A, Schatzkin A, Leitzmann MF.

Cancer Causes Control. 2008 Nov;19(9):939-53. doi: 10.1007/s10552-008-9159-0. Epub 2008 Apr 25.

13.

Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.

Talseth BA, Ashton KA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Int J Cancer. 2008 Mar 15;122(6):1273-7.

14.

Hyperhomocysteinemia in women with advanced breast cancer.

Gatt A, Makris A, Cladd H, Burcombe RJ, Smith JM, Cooper P, Thompson D, Makris M.

Int J Lab Hematol. 2007 Dec;29(6):421-5. Erratum in: Int J Lab Hematol. 2008 Feb;30(1):87.

PMID:
17988296
15.

MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer.

Mrkonjic M, Raptis S, Green RC, Monga N, Daftary D, Dicks E, Younghusband HB, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B.

Carcinogenesis. 2007 Dec;28(12):2575-80. Epub 2007 Oct 17.

PMID:
17942459
16.

Simple formulas for gauging the potential impacts of population stratification bias.

Lee WC, Wang LY.

Am J Epidemiol. 2008 Jan 1;167(1):86-9. Epub 2007 Sep 19.

PMID:
17881384
17.

[Dietary survey in Hungary, 2003-2004. Micronutrients: vitamins].

Zajkás G, Bíró L, Greiner E, Szórád I, Agoston H, Balázs A, Vitrai J, Hermann D, Boros J, Németh R, Kéki Z, Martos E.

Orv Hetil. 2007 Aug 26;148(34):1593-600. Hungarian.

PMID:
17702688
18.
19.

Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients.

Ozkan Y, Yardim-Akaydin S, Firat H, Calişkan-Can E, Ardiç S, Simşek B.

Anticancer Res. 2007 Mar-Apr;27(2):1185-9.

20.

Body mass and colorectal cancer risk in the NIH-AARP cohort.

Adams KF, Leitzmann MF, Albanes D, Kipnis V, Mouw T, Hollenbeck A, Schatzkin A.

Am J Epidemiol. 2007 Jul 1;166(1):36-45. Epub 2007 Apr 21.

PMID:
17449892

Supplemental Content

Support Center